In abnormal cell proliferation in cancer, Scd1 expression is increased, and the cell proliferation is suppressed by treatment with PPAR-γ agonists, although the changes in Scd1 expression are not always consistent [16, 40, 41]. This evidence concerns the gene PPARG and cancer.